Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration
September 06, 2012 09:32 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., and CAMBRIDGE, UK, Sept. 6, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small...
Astex Pharmaceuticals to Participate on Epigenetics Panel at Rodman & Renshaw Conference
September 04, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at September Investor Conferences
August 30, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
August 20, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Aug. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Reports 2012 Second Quarter Financial Results
July 30, 2012 16:00 ET
|
Astex Pharmaceuticals, Inc.
Dacogen Royalty Revenue Increased 25% From Prior Year
$5.4 Million Earned on Phase I Trial Initiation of FGFR Kinase Inhibitor
Dacogen Receives Positive Regulatory Recommendation in the EU for...
Astex Pharmaceuticals to Announce 2012 Second Quarter Financial Results on July 30, 2012
July 24, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
DACOGEN(R) Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia
July 20, 2012 10:34 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Board Member Wins 2012 European Mediscience Award
July 10, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Initiation of the Phase 2 Expansion of the SGI-110 Clinical Trial in MDS and AML Patients
June 22, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 22, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor
June 13, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...